Literature DB >> 21983232

Future direct and indirect costs of obesity and the influence of gaining weight: results from the MONICA/KORA cohort studies, 1995-2005.

S B Wolfenstetter1.   

Abstract

Over the last two decades, the prevalence of obesity has risen worldwide. As obesity is a confirmed risk factor for a number of diseases, its increasing prevalence nurtures the supposition that obesity may present a growing and significant economic burden to society. The objective of this study is to analyse the correlation between body mass index (BMI) and future direct and indirect costs, as well as the correlation between changing BMI and future in(direct) costs. Health care utilisation and productivity losses were based on data from 2581 participants aged 25-65 years (1994/95) from two cross-sectional, population-representative health surveys (MONICA/KORA-survey-S3 1994/95 and follow-up KORA-survey-F3 2004/05) in Augsburg, Germany. The predicted average adjusted total direct costs per year and per user were estimated to be €1029-(healthy weight), €1093-(overweight) and €1040-(obesity). There are significantly greater future costs in the utilisation of general practitioners per user and per year at higher obesity levels (€72; €75; €96). The average total direct costs per person for those who stay in the same BMI class are €982, €1000 and €973. An overweight participant who becomes obese incurs significant costs of internists of €160 compared with those who remain overweight (€124). An overweight user incurs indirect costs of €2474, compared with €2136 for those who remain a healthy weight. There is a trend for higher predicted (in)direct costs when people are overweight or obese compared with healthy weight persons 10 years earlier. Potential cost savings could be attained if preventive programs effectively targeted these individuals.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21983232     DOI: 10.1016/j.ehb.2011.08.008

Source DB:  PubMed          Journal:  Econ Hum Biol        ISSN: 1570-677X            Impact factor:   2.184


  14 in total

1.  The influence of obesity and overweight on medical costs: a panel data perspective.

Authors:  Toni Mora; Joan Gil; Antoni Sicras-Mainar
Journal:  Eur J Health Econ       Date:  2014-01-21

2.  Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL).

Authors:  Nina Riedel; Katharina Laubner; Anne Lautenbach; Gerhard Schön; Matthias Schlensak; Rainer Stengel; Thomas Eberl; Frank Dederichs; Jens Aberle; Jochen Seufert
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

3.  Images of a Healthy Worksite: A Group-Randomized Trial for Worksite Weight Gain Prevention With Employee Participation in Intervention Design.

Authors:  I Diana Fernandez; Nancy P Chin; Carol M Devine; Ann M Dozier; Camille A Martina; Scott McIntosh; Kelly Thevenet-Morrison; Hongmei Yang
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

4.  A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels.

Authors:  Nina Sauer; Thomas Rösch; Jennifer Pezold; Franziska Reining; Mario Anders; Stefan Groth; Guido Schachschal; Oliver Mann; Jens Aberle
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

5.  Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Authors:  Mark A Espeland; Henry A Glick; Alain Bertoni; Frederick L Brancati; George A Bray; Jeanne M Clark; Jeffrey M Curtis; Caitlin Egan; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Helen P Hazuda; James O Hill; Don Hire; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Tina Killean; Abbas E Kitabchi; William C Knowler; Andrea Kriska; Cora E Lewis; Marsha Miller; Maria G Montez; Anne Murillo; David M Nathan; Ebenezer Nyenwe; Jennifer Patricio; Anne L Peters; Xavier Pi-Sunyer; Henry Pownall; J Bruce Redmon; Julia Rushing; Donna H Ryan; Monika Safford; Adam G Tsai; Thomas A Wadden; Rena R Wing; Susan Z Yanovski; Ping Zhang
Journal:  Diabetes Care       Date:  2014-09       Impact factor: 19.112

6.  Process evaluation outcomes from a global child obesity prevention intervention.

Authors:  Simone Pettigrew; Jean Michel Borys; Hugues Ruault du Plessis; Lea Walter; Terry T-K Huang; Jeffrey Levi; Jan Vinck
Journal:  BMC Public Health       Date:  2014-07-28       Impact factor: 3.295

7.  Body weight changes and outpatient medical care utilisation: Results of the MONICA/KORA cohorts S3/F3 and S4/F4.

Authors:  Silke B Wolfenstetter; Petra Menn; Rolf Holle; Andreas Mielck; Christa Meisinger; Thomas von Lengerke
Journal:  Psychosoc Med       Date:  2012-10-25

8.  Cost analyses of obesity in Canada: scope, quality, and implications.

Authors:  Stefan Kuhle; Arto Ohinmaa; Bach Xuan Tran; Amrita V Nair; Paul J Veugelers
Journal:  Cost Eff Resour Alloc       Date:  2013-02-08

9.  Impact of BMI and BMI change on future drug expenditures in adults: results from the MONICA/KORA cohort study.

Authors:  Christina M Teuner; Petra Menn; Margit Heier; Rolf Holle; Jürgen John; Silke B Wolfenstetter
Journal:  BMC Health Serv Res       Date:  2013-10-19       Impact factor: 2.655

10.  Area level deprivation is an independent determinant of prevalent type 2 diabetes and obesity at the national level in Germany. Results from the National Telephone Health Interview Surveys 'German Health Update' GEDA 2009 and 2010.

Authors:  Werner Maier; Christa Scheidt-Nave; Rolf Holle; Lars E Kroll; Thomas Lampert; Yong Du; Christin Heidemann; Andreas Mielck
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.